Nanoparticles for Drug Delivery

At Adalid, we develop next-generation lipid nanoparticles for gene delivery. We strongly believe that the next-generation of LNPs depends not only on the design of ionizable lipids that drive delivery efficacy, but also on a fully tunable overall composition tailored to meet the specific requirements of each therapeutic application.

Our technology encompasses the design and synthesis of ionizable lipids with tunable properties, customizable compositions tailored to specific needs (e.g., multi-cargo delivery, prolonged blood circulation), and advanced outer shell architectures that enable flexible attachment of targeting moieties, omitting PEG-lipid.